期刊文献+

一种新的组织块培养肿瘤药敏试验法 被引量:4

A new in vitro tumor chemosensitivity assay based on tissue culture
原文传递
导出
摘要 目的:建立一种简便、可靠、快速的肿瘤药敏试验新方法。方法:采用组织块培养、MTT染色和计算机图像分析法测定药物对肿瘤细胞的作用;测定加MTT后不同时间显色反应及非特异性染色以确定试验条件;对同一份标本进行3次试验以观察重复性;对人癌裸鼠移植瘤进行药敏试验以评价本试验鉴别敏感/耐药的能力;对127份临床肿瘤标本进行药敏试验,观察试验成功率。结果:加MTT反应时间以3h为合适,试验变异系数为9.4%,本试验可鉴别移植瘤的耐药性,对临床肿瘤标本试验成功率90.6%。结论:组织块培养、MTT染色和计算机图像分析的肿瘤药敏系统具有简便、可靠、快速的特点,可指导临床个体化肿瘤化疗。 Objective :This study is to establish a simple operation, reliable and rapid manner for tumor chemosensitivity assay in vitro. Methods:The effect of drug on tumor cell was evaluated with tissue cuhure-MTT endpoint-image analysis system. The assay condition was determined by analyzing the stability of color reaction and the non-special color reaction after adding MTT. The repeat character was evaluated by 3 assays on same sample. The ability of the assay to distinguish drug-resistance was evaluated by the assays on cancer xenografts in nude mice of 4 pair human tumor sensitivity/drug-resistance cell lines. The success rate was evaluated by assays of 127 clinic tumor samples. Results :The optimum time of color reaction was at 3 hour point after adding MTT. The coefficient of variation was 9.4%. The assay distinguished drug-resistance. The success rate of assay of 127 clinic tumor samples was 90. 6% . Conclusion:The assay may be promising to develop as a useful method for individual cancer chemotherapy.
出处 《中国新药杂志》 CAS CSCD 北大核心 2009年第18期1793-1797,共5页 Chinese Journal of New Drugs
基金 广州市科技攻关项目(2007Z3-E4121)
关键词 肿瘤 体外药敏试验 组织块培养 tumor tumor chemosensitivity assay tissue culture
  • 相关文献

参考文献11

  • 1MERCER SJ,SOMERS SS,KNIGHT LA, et al. Heterogeneity of chemosensitivity of esophageal and gastric carcinoma [ J ]. Anticancer Drugs, 2003, 14(6) : 397 -403.
  • 2HAMBURGER AW,SALMON SE. Primary bioassay of human tumor stem cells[ J]. Science, 1977,197 (4302) :461 - 463.
  • 3FRIEDMAN HM ,GLAUBINGER DL. Assessment of in vitro drug sensitivity of human tumor cells using (3H) thymidine incorporation in a modified human tumor stem cell assay [ J ]. Cancer Res, 1982, 42( 11 ) :4683 -4689.
  • 4SEVIN BU, PENG ZL, PERRAS JP, et al. Application of an ATP - bioluminescence assay in human tumor chemosensitivity testing [ J ]. Gynecol Oncol, 1988, 31 ( 1 ) : 191 - 204.
  • 5YAMAUE H, TANIMURA H, NAKAMORI M, et al. Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay[J]. Dis Colon Rectum,1996 39(4) :416 -422.
  • 6WEISENTHAL LM, MARSDEN JA, DILL PL, et al. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors [ J ]. Cancer Res, 1983, 43 ( 2 ) : 749 - 757.
  • 7MAITLAND ML, DIRIENZO A, RATAIN MJ. Interpretingdisparate responses to cancer therapy: the role of human population genetics[J]. J Clin Oncol,2006,24(14) : 2151 -2157.
  • 8MUERKOSTER S,WEGEHENKEL K,ARLT A,et al. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effectsof nitric oxide and interleukin-1 beta [ J ] , Cancer Res,2004,64 (4) : 1331 - 1337.
  • 9FRISCH SM, RUOSLAHTI E. Integrins and anoikls [ J ]. Curr Opin Cell Biol, 1997,9 ( 5 ) :701 - 706.
  • 10HORNING JL, SAHOO SK, VIJAYARAGHAVALU S, et al. 3- D tumor model for in vitro evaluation of anticancer drugs[ J ]. Mol Pharm, 2008,5 ( 5 ) : 849 - 862.

同被引文献42

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部